Morgan Stanley upgraded Bunge (BG) to Overweight from Equal Weight with a price target of $120, up from $95. The firm says synergy optionality creates a favorable risk/reward in shares of Bunge. The Viterra synergies will likely surprise positively, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BG:
